Apollo Hospitals Q3FY26: PAT up 35%, declares Rs 10 interim dividend
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty 100 and 2.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Apollo Hospitals reported Q3FY26 consolidated revenue of Rs 6,477 crore, up 17% YoY. EBITDA grew 27% to Rs 965 crore. PAT rose 35% to Rs 502 crore. Diluted EPS stood at Rs 34.94. For 9M FY26, revenue grew 15% to Rs 18,623 crore and PAT rose 34% to Rs 1,412 crore. Board declared an interim dividend of Rs 10 per share, 200% on face value of Rs 5. Record date Feb 16, payment by Feb 27.
Strong Q3 with broad growth across hospital, pharmacy and digital verticals. Interim dividend rewards shareholders. Demerger scheme filed with NCLT.